Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-5QS67N4551? Is UNII-5QS67N4551 safe for nursing mother and child? Does UNII-5QS67N4551 extracts into breast milk? Does UNII-5QS67N4551 has any long term or short term side effects on infants? Can UNII-5QS67N4551 influence milk supply or can UNII-5QS67N4551 decrease milk supply in lactating mothers?

Answer by DrLact: About UNII-5QS67N4551 usage in lactation

UNII-5QS67N4551 [human] is a serine proteinase inhibitor derived from human plasma that is used in treating hereditary angioedema. Breastmilk levels of UNII-5QS67N4551 have not been measured after exogenous administration in humans. Because of its large molecular weight, amounts in milk are expected to be small. Any UNII-5QS67N4551 in breastmilk is probably destroyed in the infant's gastrointestinal tract and not absorbed, except perhaps in neonates. Various international consensus panels state that human plasma-derived UNII-5QS67N4551 is considered to be the therapy of choice for both treatment and prophylaxis of maternal hereditary angioedema during lactation.[1][2]

UNII-5QS67N4551 Side Effects in Breastfeeding

Three patients with hereditary angioedema received UNII-5QS67N4551 concentrate on 12 occasions to relieve abdominal edematous episodes during breastfeeding. No adverse reactions were reported.[3] In a case series spanning 12 years, 21 mothers with hereditary angioedema breastfed their infants for a median duration of 4.8 months (range 1 to 34 months) while receiving UNII-5QS67N4551 concentrate as needed. No side effects occurred tin the breastfed infants.[4] A pregnant woman with severe hereditary angioedema required 500 IU of C1 inhibitor concentrate every 2 days to maintain her pregnancy. Postpartum, she received 500 IU on demand while breastfeeding. She used 88 vitals during her 6-month breastfeeding (extent not stated) period. No side effects or viral transmission were reported and or virus anti-C1-INH antibodies were not detected.[5] A woman with hereditary angioedema received C1 inhibitor concentrate 1000 units every week during pregnancy. Postpartum she used 500 units as needed. She and her breastfed infant were reportedly healthy.[6]

Alternate Drugs

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.